Efficacy and Safety of TELMINUVO to Stage 2 Hypertension
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT01983735
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 200 participants
- Registry
-
NCT01983735
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT01983735. Randomized; triple masking; primary purpose treatment. Start 2014-01 (registry gives no type); primary completion 2014-08 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of TELMINUVO to Stage 2 Hypertension
- Condition
- Hypertension
- Intervention (Drug)
- TELMINUVO Tab. (80/2.5mg)
- Intervention (Drug)
- TELMINUVO Tab. (80/5mg)
- Intervention (Drug)
- S-amlodipine 2.5mg
- Intervention (Drug)
- S-amlodipine 5mg
- Lead sponsor
- Chong Kun Dang Pharmaceutical
Record details
- Record id
cardio:ct-nct01983735- Content hash
f787ad7a1b127e056f131ace175ec3895c16f418ff56d8848b19c4214e46e1be